Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Pharmacogenomic Testing Draws $26 Million Recoupment from Medicare Audit

Repayment demand to pharmacogenomic testing lab could be a sign that federal payers can't afford PGX

This is an excerpt from a 1,340-word article in the January 9 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: Pharmacogenomic testing is expected to be a linchpin to the practice of …

Pharmacogenomic Testing Draws $26 Million Recoupment from Medicare Audit Read More »

To access this post, you must purchase The Dark Report.

Comments

;